The INK4a/ARF tumor suppressor: One gene-two products-two pathways

Lynda Chin, Jason Pomerantz, Ronald A. Depinho

Research output: Contribution to journalReview articlepeer-review

257 Scopus citations

Abstract

Functional inactivation of the retinoblastoma (RB) and p53 pathways appears to be a rite of passage for all cancerous cells and results in disruption of cell-cycle regulation and deactivation of the apoptotic response that normally ensues. The INKa/ARF locus sits at the nexus of these two growth-control pathways, by virtue of its ability to generate two distinct products: the p16(INKa) protein, a cyclin-dependent kinase inhibitor that functions upstream of RB; and the p19(ARF) protein, which blocks MDM2 inhibition of p53 activity. This 'one gene-two products-two pathways' arrangement provides a basis for the prominence of INKa/ARF in tumorgenesis. Copyright (C) 1998 Elsevier Science Ltd.

Original languageEnglish (US)
Pages (from-to)291-296
Number of pages6
JournalTrends in Biochemical Sciences
Volume23
Issue number8
DOIs
StatePublished - Aug 1 1998

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Fingerprint

Dive into the research topics of 'The INK4a/ARF tumor suppressor: One gene-two products-two pathways'. Together they form a unique fingerprint.

Cite this